FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 7micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norelgestromin 150micrograms/24hours / Ethinylestradiol 20micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 6mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 10mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 15mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 80micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 37.5micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 75micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 25micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 40micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 20micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 5mg/16hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine hydrobromide 1mg/72hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 100micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 21mg/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Generic Salonpas medicated plasters Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 200micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours / Levonorgestrel 10micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Oxybutynin 3.9mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 5micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 10micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 20micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Diclofenac 1% patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 2mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 4mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 6mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rotigotine 8mg/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 35micrograms/hour patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 70micrograms/hour patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Buprenorphine 52.5micrograms/hour patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 300micrograms/24hours patches Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 3 patches (Boehringer Ingelheim Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 300micrograms/24hours patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches 12 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 100micrograms/24hours patches 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) 12 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 3 patches (Boehringer Ingelheim Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (PI) (Dowelhurst Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (PI) (Dowelhurst Ltd) 9 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Product containing precisely lidocaine 50 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patches (Teva UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patches (Teva UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patches (Teva UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patches (Teva UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour patches (Teva UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour patches (Teva UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour patches (Teva UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour patches (Teva UK Ltd) 5 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
NiQuitin Clear 14mg patches (Omega Pharma Ltd) 14 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 14mg/24hours transdermal patches 14 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 7mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Hyoscine 1mg/72hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 12micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 75micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 25micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 15micrograms/hour transdermal patches (Aspire Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 100micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 12micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rebrikel 10micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rebrikel 5micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rebrikel 20micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rebrikel 20micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rebrikel 5micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rebrikel 10micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 21mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Estradiol 50micrograms/24hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicotine 5mg/16hours transdermal patches Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Waymade Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven 50 patches (Waymade Ltd) 4 patch Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Versatis 5% medicated plasters (Grunenthal Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 3 of 21 Next End

This concept is not in any reference sets

Back to Start